Updated Recommendations from ASTRO for the Adjuvant Treatment of Endometrial Cancer
Updated Recommendations from ASTRO for the Adjuvant Treatment of Endometrial Cancer
The article reports the publication of updated treatment guidelines by the American Society for Radiation Oncology (ASTRO) concerning the use of adjuvant radiotherapy in women with non‑metastatic endometrial carcinoma. The guidelines summarise contemporary evidence on the benefits and risks of vaginal brachytherapy (VBT) and external‑beam radiotherapy (EBRT), incorporating molecular biomarker data to personalise therapy. They provide specific dose recommendations and decision‑tree logic that are intended to standardise care across institutions and ultimately improve oncologic outcomes for this population.
Evidence level: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Related signals
- Immunotherapy improves endometrial cancer outcomes
- Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials
- Endometrial Cancer - PMC
- Current recommendations and recent progress in endometrial cancer
- Advancements in Endometrial Cancer Research in 2024